First study of SP-101 injection in healthy volunteers
Part of Mental health clinical trials.
This trial tests a new medicine called SP-101 given by IV infusion. It is the first time SP-101 is given to humans, and the study will check how safe it is and how the body handles it. It may help researchers decide the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 45 years old.
- You are healthy, with no major medical conditions.
- You have a body mass index (BMI) between 18 and 28.
- You weigh at least 50 kg (men) or 45 kg (women).
- You are willing to use effective birth control and avoid pregnancy or sperm donation for 3 months after the last dose.
- You can follow the study rules and attend all visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This trial tests a new medicine called MT1011 given as an injection. Researchers want to see how safe it is and how the body handles it. Healthy people can join to help find the right dose for future studies.
This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This study tests a new drug called SSS67 given as a single injection into a vein. It aims to see how safe it is in healthy adults and how the body processes it.
Hear when a new Major Depressive Disorder, Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.